ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.

Patricia S Steeg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.